Detalles de la búsqueda
1.
An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.
J Transl Med;
22(1): 321, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555418
2.
Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.
Cell Commun Signal;
22(1): 173, 2024 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462636
3.
Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer.
Cancer Immunol Immunother;
72(4): 985-1001, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251028
4.
A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy.
Pharmacol Res;
182: 106343, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35798286
5.
Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist.
Nano Lett;
21(23): 9939-9950, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779631
6.
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy.
J Am Chem Soc;
143(44): 18536-18547, 2021 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661406
7.
Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells.
Toxicol Appl Pharmacol;
420: 115523, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838154
8.
Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT.
Cell Commun Signal;
19(1): 12, 2021 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33557880
9.
Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.
Cancer Immunol Immunother;
69(8): 1493-1504, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285170
10.
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
Cell Commun Signal;
18(1): 142, 2020 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32894141
11.
A Novel d-Peptide Identified by Mirror-Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy.
Angew Chem Int Ed Engl;
59(35): 15114-15118, 2020 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32386245
12.
Bifunctional Chelating Supramolecular Polymer and Its Application in Downregulation of Cellular Iron Uptake.
Biomacromolecules;
18(9): 2830-2838, 2017 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28777551
13.
Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.
Angew Chem Int Ed Engl;
54(40): 11760-4, 2015 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259671
14.
Dual targeting of TIGIT and PD-1 with a novel small molecule for cancer immunotherapy.
Biochem Pharmacol;
223: 116162, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527557
15.
Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy.
J Control Release;
365: 654-667, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030081
16.
Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy.
Sci China Life Sci;
67(5): 996-1009, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38324132
17.
Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy.
Acta Pharm Sin B;
14(3): 1150-1165, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486998
18.
Peptide-based PET imaging agent of tumor TIGIT expression.
EJNMMI Res;
13(1): 38, 2023 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129788
19.
Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
J Exp Clin Cancer Res;
42(1): 51, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36850011
20.
Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression.
Biochem Pharmacol;
217: 115800, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696459